Increasing Vaccine Uptake in Underresourced Public Housing Areas

NCT04779138 | Completed

• 1 other identifier: vaccinehousing
• Study Type: interventional
• Target: 462
• Locations: 1 country
• Sites: 1

Brief Summary

This proposal seeks to enhance uptake and completion of COVID-19 vaccination among African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to provide education at multiple levels and implement innovate strategies to engage this population in the uptake of COVID-19 vaccination.

Conditions

Coronavirus; Vaccine Refusal

Outcome Measures

Primary Outcomes (1)

• Prevalence of vaccination uptake for COVID-19, influenza, and pneumonia using Vaccination History Self Report

  1\. By comparison of pre-, post- intervention, and 9- and 18-months follow-up data, we anticipate the following compared to baseline: a 40% change in completion of COVID-19 vaccination series

  Intervention: 4 months; Follow-up Point: 3 months post-intervention

Secondary Outcomes (2)

• Percentage of Participants Achieving Decreased Vaccine Hesitancy Levels of COVID-19 vaccine Using the NIH Toolbox Surveys on COVID-19

  Intervention: 4 months; Follow-up Point: 3 months post-intervention

• Percentage of Participants Achieving Increased Level of Behavior Change toward COVID-19 Vaccination Using the NIH Toolbox Surveys on COVID-19

  Intervention: 4 months; Follow-up Point: 3 months post-intervention

Study Arms (1)

Increasing Uptake of COVID-19 Vaccination

EXPERIMENTAL

This is a pre-experimental "one group pretest-posttest" design to increase COVID-19 vaccine uptake and completion among African American and Latinx public housing residents in South Los Angeles. The proposed intervention will employ (1) culturally sensitive, (2) theoretically based intervention that will be jointly delivered by our ACTIVATE triad leaders and our researchers. We will use the Information, Motivation, and Behavioral Skills (IMB) model and the Transtheoretical Model to implement the intervention.

Behavioral: Increasing Willingness and Uptake of COVID-19 Vaccination

Interventions

Increasing Willingness and Uptake of COVID-19 Vaccination BEHAVIORAL

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 vaccine hesitancy and increase willingness and uptake in COVID-19 vaccination.

Increasing Uptake of COVID-19 Vaccination

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• identify as Latinx or African American
• age 18 or older
• reside in one of the six collaborating public housing area
• Speak either English or Spanish

You may not qualify if:

• Not a resident at one of the collaborating public housing areas
• Does not self-identify as African American or Latinx
• Age 17 and younger
• Unable to speak either English or Spanish
• Aim 3:
• identify as Latinx or African American
• age 18 or older
• reside in one of the six collaborating public housing area
• Speak either English or Spanish
• Report vaccine hesitancy
• Not a resident at one of the collaborating public housing areas
• Does not self-identify as African American or Latinx
• Age 17 and younger
• Unable to speak either English or Spanish
• Received all recommended vaccines for COVID-19

Sponsors & Collaborators

• Charles Drew University of Medicine and Science: lead

Study Sites (1)

Charles R. Drew University of Medicine & Science

Los Angeles, California, 90059, United States

Location

MeSH Terms

Conditions

Coronavirus Infections; Vaccination Refusal

Condition Hierarchy (Ancestors)

Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Treatment Refusal; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Sharon Cobb

  Charles R. Drew University of Medicine & Science

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 27, 2021
• First Posted: March 3, 2021
• Study Start: September 11, 2021
• Primary Completion: November 30, 2023
• Study Completion: April 1, 2024
• Last Updated: April 24, 2024

Record last verified: 2024-02

Locations

US (1)